Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 55 (6) , 767-778
- https://doi.org/10.1016/0049-3848(89)90307-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222British Journal of Haematology, 1988
- Determination of plasminogen activator inhibitor in plasma using t-pa and a chromogenic single-point poly-D-lysine stimulated assayThrombosis Research, 1988
- The effect of low molecular weight heparin on experimental thrombosis and haemostasis - the influence of production methodThrombosis Research, 1987
- tPA inhibitor, tPA:Ag, plasminogen, and α2-antiplasmin after low molecular weight heparin or standard heparinFibrinolysis, 1987
- Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitroThrombosis Research, 1986
- The effect of heparin fragments of different molecular weights on experimental thrombosis and haemostasisThrombosis Research, 1985
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrateScandinavian Journal of Clinical and Laboratory Investigation, 1977
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976
- A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasminBlood, 1975